Latest News
⭐ We are pleased to announce that company has received the approval from the General Directorate of Medicines, Supplies and Drugs (DIGEMID), Peru for it's Generic, Injectable & OSD (Unit-1 in Amritsar) and for Oncology, Injectable & OSD (Unit-3 in Himachal Pradesh)
⭐ kwality develops it's first Implant injection:Goserelin Acetate Implant Injection
Contact Us
FOR ORDERS
Ibm@kwalitypharma.com
+91 9779177677
FOR QUERY
info@kwalitypharma.com
+91 7657833389
FOR JOBS
hrd@kwalitypharma.com
+91 9888014228
Customer Enquiry
Company Brochure
About
Facilities
Gallery
Investor Relations
Job Opportunities
Online Enquiry
Schedule of Analysts or Institutional Investors meet and Presentations made to them
Schedule of Analysts or Institutional Investors meet and Presentations made to them
Transcript of Earnings Conference Call held on 19-05-2026
Investor Presentation for quarter and year ended 31-03-2026
Investor Presentation for Quarter and Nine Months ended 31-12-2025
Intimation for analyst meeting 13-02-2026
Investor Presentation 2021-2022
Video Recording of Investor Meeting held on 13-Feb-2026
Audio Recording of Investor Meeting held on 13-Feb-2026
Audio Recording of Earnings Conference Call held on 19-05-2026
